Unproven peptides touting wellness have been relegated to a gray market because of Biden-era restrictions. Under the Trump administration, that could change.
Originally reported by NPR. Read the full story at the original source.
Medicare's pilot GLP-1 discount program has a catch. Some sick patients don't qualify August 30, 20265:00 AM ET From B...
The number of people living with dementia around the world is forecast to nearly triple to 153 million by 2050. Photogr...
Farm Adventures of Harmony, N.C., owned the goats, state health officials said. It was unclear how many people might hav...
From Jergens and Naturium to CeraVe and Eucerin, there’s a potion on this list that will keep every body soft and moistu...